Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?

Clinical Breast Cancer

Volumn 9, Issue 2, 2009, Pages 92-95

  Unal, Bulent ^a   Serhat Gur, Akif ^a   Ahrendt, Gretchen ^a   Johnson, Ronald ^a   Bonaventura, Marguerite ^a   Soran, Atilla ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Lymphovascular invasion; Pathologic tumor size; Receiver operating characteristic curve

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; PREDICTION; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; LUNG CARCINOMA; LYMPH NODE; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AREA UNDER CURVE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 67649770487     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2009.n.017     Document Type: Article

References (19)

1. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229:536-41.
2. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574-81.
3. Cohen L F, Breslin TM, Kuerer HM, et al. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 2000; 24:1266-72.
4. Nason KS, Anderson BO, Byrd DR, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000; 89:2187-94.
5. Gimbergues P, Abrial C, Durando X, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 2008; 15:1316-21.
6. Newman EA, Sabel MS, Nees AV, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007; 14:2946-52.
7. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999; 17:1720-6.
8. Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001; 182:316-20.
9. Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001; 136:1059-63.
10. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10:1140-51.
11. Barranger E, Coutant C, Flahault A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005; 91:113-9.
12. Pal A, Provenzano E, Duffy SW, et al. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008; 95:302-9.
13. Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008; 8:66.
14. Soran A, Falk J, Bonaventura M, et al. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity? J Am Coll Surg 2007; 205:66-71.
15. Gur AS, Unal B, Johnson R, et al. The predictive probability of four different breast cancer nomograms for non sentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 2009; 208:229-35.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology 1983; 148:839-43.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
18. Evrensel T, Johnson R, Ahrendt G, et al. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer. Int J Clin Pract 2008; 62:1379-82.
19. Jeruss JS, Newman LA, Ayers GD, et al. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 2008; 112:2646-54.